Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alnylam, Biocardia, Biomx, Cabaletta, Corcept, Eli Lilly, Fibrogen, Keros, LB, Mineralys, Nanobiotix, Novo Nordisk, Opthea, Palatin, Regulus, Sensei, Transcend, Vaxcyte, Vertex.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biontech, Irlab, Johnson & Johnson, Merck, Palatin, Shanton.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alzinova, Aelis, Candel, Chemomab, Dermata, Equillium, J&J.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aligos, Calidi, IGC, Leap, Merakris , Merakris, Vaximm, Wave Life Sciences.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Axsome, Cassava, CNS, Genelux, Kezar, Mural, Nanoscope, Newsoara, Oncotelic, Traws.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akeso, Aura, Cel-Sci, CG Oncology, Opthea, Ractigen, Unity.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Briacell, Corvus, Hyloris, Medera, Monte Rosa, Neurocrine, PTC.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acumen, Benitec, Hutchmed, Immunovant, Innovent, Maat, Novartis, Regenxbio, Roivant, Satellos, Tvardi, UCB.